샘플 요청 목록

 카트 문의
시장보고서
상품코드
2141905

바이오테크놀러지 시장

Biotechnology
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 570 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,929,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,066,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,789,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오테크놀러지 시장은 2032년까지 5조 달러에 달할 전망

2025년에 2조 1,000억 달러로 추정되는 세계의 바이오테크놀러지 시장은 2032년까지 5조 달러에 달할 것으로 전망되고, 2025년부터 2032년까지 분석 기간 동안 CAGR 13.3%로 성장할 것으로 예측됩니다. 이 보고서에서 분석 대상이 되고 있는 부문 중 하나인 바이오의약품은 CAGR 15.3%를 기록하며 분석 기간 종료까지 1조 5,000억 달러에 달할 것으로 예상됩니다. 바이오프로세스 장비·소모품 부문의 성장률은 분석 기간 중 CAGR 14.8%로 추정됩니다.

미국 시장은 5,676억 달러로 추정되는 한편 중국은 CAGR 17.6%로 성장할 것으로 예측

2025년 미국의 바이오테크놀러지 시장 규모는 5,676억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025년부터 2032년까지의 분석 기간 동안 CAGR 17.6%를 기록하며 2032년까지 시장 규모가 1조 1,000억 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 9.9% 및 12.3%로 성장할 것으로 예측됩니다. 유럽내에서는 독일이 CAGR 약 10.7%로 성장할 것으로 예측됩니다.

세계의 바이오테크놀러지 시장 - 주요 동향과 촉진요인 개요

바이오테크놀러지는 의료와 농업에 어떤 변화를 가져오고 있을까요?

바이오테크놀러지는 생물학적 시스템을 활용하여 혁신적인 제품과 솔루션을 개발함으로써 의료, 농업 및 산업 공정 분야를 근본적으로 변화시키고 있습니다. 의료 분야에서는 생명공학을 통해 유전자 편집, 단일클론 항체, 백신과 같은 생명을 구하는 치료법의 개발이 가능해졌습니다. 또한, 개인의 유전적 구성에 맞춰 치료법을 조정하는 ‘맞춤형 의료’의 발전에서도 매우 중요한 역할을 하고 있습니다. 농업 분야에서는 생명공학을 통해 수확량 증대, 해충 저항성, 영양가 향상을 실현하는 유전자 변형 작물이 개발되어, 전 세계 식량 안보 문제 해결에 기여하고 있습니다. 생명공학의 역할은 산업 분야로도 확대되어, 바이오 기반 제품과 공정이 기존의 화학 기반 방식을 대체함으로써 보다 지속가능한 제조 관행을 촉진하고 있습니다.

바이오테크놀러지의 미래를 형성하고 있는 기술적 진보는 무엇일까요?

CRISPR를 이용한 유전자 편집, 합성생물학, 바이오 제조와 같은 기술적 진보가 생명공학의 미래를 형성하는 최전선에 있습니다. 특히 CRISPR는 DNA를 정밀하게 변형할 수 있게 하여, 유전병 치료, 작물의 형질 개량, 보다 효율적인 바이오연료 창출에 새로운 가능성을 열어줌으로써 유전자 연구에 혁명을 일으켰습니다. 새로운 생물학적 구성요소나 시스템을 설계하는 합성생물학은 바이오엔지니어링 등의 분야에서 혁신을 주도하고 있으며, 이곳에서는 미생물을 변형시켜 의약품에서 바이오 기반 플라스틱에 이르기까지 모든 것을 생산하고 있습니다. 한편, 연속 제조나 일회용 시스템의 활용과 같은 바이오 제조 기술은 생물학적 제제 및 기타 생명공학 제품의 생산에서 확장성과 효율성을 높이고 있습니다.

바이오테크놀러지의 성장을 주도하고 있는 분야는 무엇일까요?

바이오테크놀러지 시장은 헬스케어, 농업, 산업용 생명공학 등 몇 가지 주요 부문에 걸쳐 있습니다. 헬스케어 분야에서는 생물학적 제제, 유전자 치료, 맞춤형 의료에 대한 수요가 생명공학 연구 개발에 대한 막대한 투자를 이끌고 있습니다. 농업 분야에서는 유전자 변형 생물(GMO) 및 바이오 유래 비료·농약의 도입이 지속가능한 식량 생산에 대한 전 세계적 수요를 충족시키는 데 기여하고 있습니다. 산업용 생명공학도 급속한 성장을 이루고 있으며, 특히 바이오연료, 생분해성 플라스틱, 그리고 제조 공정에 사용되는 효소 생산 분야에서 두드러집니다. 생명공학 솔루션이 가져다주는 환경적 이점, 특히 탄소발자국 감소와 화학 폐기물 최소화는 산업 전반에 걸친 적용 범위를 더욱 확대시키고 있습니다.

어떤 요인들이 이러한 성장을 주도하고 있을까요?

바이오테크놀러지 시장의 성장은 유전자 공학 기술의 발전, 헬스케어 분야의 연구 개발(R&D)에 대한 투자 확대, 그리고 지속가능한 농업 솔루션에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 헬스케어 분야에서는 맞춤형 의료의 부상과 생물학적 제제에 대한 수요가 주요 촉진요인으로 작용하고 있는 반면, 농업 바이오테크놀러지 시장에서는 내성이 더 강하고 지속가능한 작물에 대한 필요성이 높아지고 있습니다. 또한, 산업 분야에서도 기업들이 환경에 미치는 영향을 줄이려는 노력 속에서 바이오 기반 생산 방식이 확대되고 있습니다. 생명공학 혁신에 대한 규제 측면의 지원과 유전자 변형 작물(GMO) 및 생물학적 제제에 대한 대중의 수용도 증가 또한 시장 확대에 더욱 기여하고 있습니다.

부문 :

유형(바이오의약품, 바이오프로세스 장비·소모품, 시약·키트, 바이오 서비스, 바이오정보학·플랫폼·소프트웨어, 기타), 기술(DNA 시퀀싱 기술, 나노바이오 기술, 조직공학·재생 기술, PCR 기술, 크로마토그래피 기술, 유전자 증폭 기술, 합성생물학 기술, CRISPR 및 유전자 편집 도구 기술, 바이오칩·마이크로어레이 기술, 기타 기술), 용도(의료·레드 바이오테크놀러지 용도, 식품·농업 용도, 산업 공정 용도, 환경·천연자원 용도, 바이오정보학·오믹스 용도, 기타 용도), 최종 용도(바이오의약품·바이오기술 기업용, CMO·CRO용, 학술·연구 기관용, 병원·진단 센터용, 농업 기업용, 기타 최종 용도)

주요 기업

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Merck KgaA
  • PerkinElmer, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

해당 분야의 전문가들의 관점을 바탕으로 함 - 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용 - 컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업의 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 면밀히 검토합니다.

주요 지역의 시장 점유율 분석 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구조는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞춰 상세도를 조정하여 주요 지역의 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 26.10.12

Global Biotechnology Market to Reach US$5.0 Trillion by 2032

The global market for Biotechnology estimated at US$2.1 Trillion in the year 2025, is expected to reach US$5.0 Trillion by 2032, growing at a CAGR of 13.3% over the analysis period 2025-2032. Biopharmaceuticals Type, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$1.5 Trillion by the end of the analysis period. Growth in the Bioprocess Equipment & Consumables Type segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$567.6 Billion While China is Forecast to Grow at 17.6% CAGR

The Biotechnology market in the U.S. is estimated at US$567.6 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Trillion by the year 2032 trailing a CAGR of 17.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global Biotechnology Market - Key Trends & Drivers Summarized

How Is Biotechnology Revolutionizing Medicine and Agriculture?

Biotechnology is fundamentally transforming the fields of medicine, agriculture, and industrial processes by harnessing biological systems to develop innovative products and solutions. In medicine, biotechnology has enabled the development of life-saving therapies such as gene editing, monoclonal antibodies, and vaccines. It is also pivotal in advancing personalized medicine, where treatments are tailored to an individual’s genetic makeup. In agriculture, biotechnology has led to the development of genetically modified crops that offer higher yields, pest resistance, and improved nutritional content, helping to address global food security challenges. The role of biotechnology extends to industrial applications, where bio-based products and processes are replacing traditional chemical-based methods, fostering more sustainable manufacturing practices.

What Technological Advancements Are Shaping the Future of Biotechnology?

Technological advancements such as CRISPR gene-editing, synthetic biology, and biomanufacturing are at the forefront of shaping the future of biotechnology. CRISPR, in particular, has revolutionized genetic research by enabling precise modifications to DNA, opening new possibilities in curing genetic diseases, improving crop traits, and creating more efficient biofuels. Synthetic biology, which involves designing new biological components or systems, is driving innovation in fields like bioengineering, where microbes are engineered to produce everything from pharmaceuticals to bio-based plastics. Meanwhile, biomanufacturing techniques, such as continuous manufacturing and the use of single-use systems, are enhancing the scalability and efficiency of producing biologic drugs and other biotech products.

What Sectors Are Driving Biotechnology Growth?

The biotechnology market spans several key sectors, including healthcare, agriculture, and industrial biotechnology. In healthcare, the demand for biologic drugs, gene therapies, and personalized medicine is driving significant investment in biotech research and development. In agriculture, the adoption of genetically modified organisms (GMOs) and bio-based fertilizers and pesticides is helping to meet the global demand for sustainable food production. Industrial biotechnology is also witnessing rapid growth, particularly in the production of biofuels, biodegradable plastics, and enzymes used in manufacturing processes. The environmental benefits of biotech solutions, especially in reducing carbon footprints and minimizing chemical waste, are further expanding its applications across industries.

What Factors Are Driving Growth?

The growth in the biotechnology market is driven by several factors, including advancements in genetic engineering technologies, increasing investments in healthcare R&D, and the growing need for sustainable agricultural solutions. The rise of personalized medicine and the demand for biologic drugs are key drivers in the healthcare sector, while the need for more resilient and sustainable crops is boosting the agricultural biotech market. Additionally, the industrial sector is experiencing growth in bio-based production methods as companies aim to reduce environmental impact. The regulatory support for biotech innovations and the increasing public acceptance of GMOs and biologic therapies are further contributing to market expansion.

SCOPE OF STUDY:

The report analyzes the Biotechnology market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type, Other Types); Technology (DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology, Other Technologies); Application (Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application, Other Applications); End-Use (Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Merck KgaA
  • PerkinElmer, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Biotechnology - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 93 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biotechnology in Drug Development and Personalized Medicine
    • Technological Innovations in CRISPR, Gene Editing, and Synthetic Biology
    • Growing Applications of Biotechnology in Agriculture for GMO Crops and Biofertilizers
    • Advancements in Biomanufacturing Processes Driving Efficiency and Scalability
    • Expanding Role of Biotechnology in Environmental Sustainability and Biofuels
    • Increasing Investments in Healthcare and Biopharmaceutical Research & Development
    • Rising Adoption of Biotechnology in Diagnostics and Precision Medicine
    • Opportunities for Biotechnology Expansion in Emerging Markets
    • Growing Focus on Biotechnological Solutions to Address Climate Change and Global Food Security
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 5: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 6: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 7: World Biotechnology Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Biopharmaceuticals Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Biopharmaceuticals Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Bioprocess Equipment & Consumables Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Bioprocess Equipment & Consumables Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Reagents & Kits Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Reagents & Kits Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Bioservices Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Bioservices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Bioinformatics Platforms & Software Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Bioinformatics Platforms & Software Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for DNA Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for DNA Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Nanobiotechnology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Nanobiotechnology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Tissue Engineering & Regeneration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Tissue Engineering & Regeneration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for PCR Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for PCR Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 41: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 42: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: World 13-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 44: World Recent Past, Current & Future Analysis for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 45: World Historic Review for Gene Amplification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: World 13-Year Perspective for Gene Amplification Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 47: World Recent Past, Current & Future Analysis for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 48: World Historic Review for Synthetic Biology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: World 13-Year Perspective for Synthetic Biology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 50: World Recent Past, Current & Future Analysis for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 51: World Historic Review for CRISPR & Gene-Editing Tools Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: World 13-Year Perspective for CRISPR & Gene-Editing Tools Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 53: World Recent Past, Current & Future Analysis for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 54: World Historic Review for Biochips & Microarrays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: World 13-Year Perspective for Biochips & Microarrays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 56: World Recent Past, Current & Future Analysis for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 57: World Historic Review for Health & Red Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: World 13-Year Perspective for Health & Red Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 59: World Recent Past, Current & Future Analysis for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 60: World Historic Review for Food & Agriculture Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: World 13-Year Perspective for Food & Agriculture Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 62: World Recent Past, Current & Future Analysis for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 63: World Historic Review for Industrial Processing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: World 13-Year Perspective for Industrial Processing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 65: World Recent Past, Current & Future Analysis for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 66: World Historic Review for Environmental & Natural Resources Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: World 13-Year Perspective for Environmental & Natural Resources Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 68: World Recent Past, Current & Future Analysis for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 69: World Historic Review for Bioinformatics & Omics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: World 13-Year Perspective for Bioinformatics & Omics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 71: World Recent Past, Current & Future Analysis for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 72: World Historic Review for Biopharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: World 13-Year Perspective for Biopharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 74: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 75: World Historic Review for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: World 13-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 77: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 78: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: World 13-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 80: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 81: World Historic Review for Hospitals & Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: World 13-Year Perspective for Hospitals & Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 83: World Recent Past, Current & Future Analysis for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 84: World Historic Review for Agricultural Corporations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: World 13-Year Perspective for Agricultural Corporations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 86: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 87: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 89: USA Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: USA Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: USA 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 92: USA Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: USA Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: USA 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 95: USA Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: USA Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: USA 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 98: USA Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: USA Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: USA 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 101: Canada Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Canada Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Canada 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 104: Canada Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Canada Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Canada 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 107: Canada Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: Canada Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: Canada 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 110: Canada Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: Canada Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: Canada 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • JAPAN
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 113: Japan Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: Japan Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: Japan 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 116: Japan Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Japan Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: Japan 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 119: Japan Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Japan Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: Japan 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 122: Japan Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Japan Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Japan 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CHINA
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 125: China Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: China Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: China 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 128: China Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: China Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: China 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 131: China Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: China Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: China 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 134: China Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: China Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: China 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • EUROPE
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 137: Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 140: Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 143: Europe Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 144: Europe Historic Review for Biotechnology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Europe 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 146: Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 149: Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • FRANCE
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 152: France Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: France Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: France 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 155: France Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: France Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: France 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 158: France Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: France Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: France 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 161: France Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: France Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: France 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • GERMANY
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 164: Germany Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Germany Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Germany 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 167: Germany Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Germany Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Germany 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 170: Germany Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Germany Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: Germany 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 173: Germany Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Germany Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: Germany 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 176: Italy Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Italy Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: Italy 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 179: Italy Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Italy Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: Italy 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 182: Italy Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Italy Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Italy 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 185: Italy Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Italy Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Italy 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 188: UK Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: UK Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: UK 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 191: UK Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: UK Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: UK 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 194: UK Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: UK Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: UK 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 197: UK Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: UK Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: UK 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 200: Spain Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Spain Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Spain 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 203: Spain Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Spain Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Spain 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 206: Spain Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Spain Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Spain 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 209: Spain Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Spain Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Spain 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 212: Russia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Russia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Russia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 215: Russia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Russia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Russia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 218: Russia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Russia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Russia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 221: Russia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Russia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Russia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Rest of Europe 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Rest of Europe Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Rest of Europe 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Rest of Europe Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Rest of Europe 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Rest of Europe Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Rest of Europe 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 237: Asia-Pacific Historic Review for Biotechnology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Asia-Pacific 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Asia-Pacific 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Asia-Pacific 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Asia-Pacific Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Asia-Pacific 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Asia-Pacific Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Asia-Pacific 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 251: Australia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Australia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Australia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 254: Australia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Australia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Australia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 257: Australia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Australia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Australia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 260: Australia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Australia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Australia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 263: India Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: India Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: India 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 266: India Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: India Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: India 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 269: India Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: India Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: India 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 272: India Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: India Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: India 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 275: South Korea Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: South Korea Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: South Korea 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 278: South Korea Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: South Korea Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: South Korea 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 281: South Korea Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: South Korea Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: South Korea 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 284: South Korea Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: South Korea Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: South Korea 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 287: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Rest of Asia-Pacific Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Rest of Asia-Pacific 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 290: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Rest of Asia-Pacific Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Rest of Asia-Pacific 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 293: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Rest of Asia-Pacific Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Rest of Asia-Pacific 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 296: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Rest of Asia-Pacific Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Rest of Asia-Pacific 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 299: Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 302: Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 305: Latin America Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 306: Latin America Historic Review for Biotechnology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Latin America 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 308: Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 311: Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 313: Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 314: Argentina Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 315: Argentina Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 316: Argentina 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 317: Argentina Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 318: Argentina Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 319: Argentina 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 320: Argentina Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 321: Argentina Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 322: Argentina 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 323: Argentina Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 324: Argentina Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 325: Argentina 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 326: Brazil Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 327: Brazil Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 328: Brazil 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 329: Brazil Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 330: Brazil Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 331: Brazil 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 332: Brazil Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 333: Brazil Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 334: Brazil 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 335: Brazil Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 336: Brazil Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 337: Brazil 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 338: Mexico Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 339: Mexico Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 340: Mexico 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 341: Mexico Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 342: Mexico Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 343: Mexico 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 344: Mexico Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 345: Mexico Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 346: Mexico 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 347: Mexico Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 348: Mexico Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 349: Mexico 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 350: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 351: Rest of Latin America Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 352: Rest of Latin America 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 353: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 354: Rest of Latin America Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 355: Rest of Latin America 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 356: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 357: Rest of Latin America Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 358: Rest of Latin America 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 359: Rest of Latin America Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 360: Rest of Latin America Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 361: Rest of Latin America 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 362: Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 363: Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 364: Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 365: Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 366: Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 367: Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 368: Middle East Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 369: Middle East Historic Review for Biotechnology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 370: Middle East 13-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 371: Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 372: Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 373: Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 374: Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 375: Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 376: Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 377: Iran Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 378: Iran Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 379: Iran 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 380: Iran Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 381: Iran Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 382: Iran 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 383: Iran Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 384: Iran Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 385: Iran 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 386: Iran Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 387: Iran Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 388: Iran 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 389: Israel Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 390: Israel Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 391: Israel 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 392: Israel Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 393: Israel Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 394: Israel 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 395: Israel Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 396: Israel Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 397: Israel 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 398: Israel Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 399: Israel Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 400: Israel 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 401: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 402: Saudi Arabia Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 403: Saudi Arabia 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 404: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 405: Saudi Arabia Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 406: Saudi Arabia 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 407: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 408: Saudi Arabia Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 409: Saudi Arabia 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 410: Saudi Arabia Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 411: Saudi Arabia Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 412: Saudi Arabia 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 413: UAE Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 414: UAE Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 415: UAE 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 416: UAE Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 417: UAE Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 418: UAE 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 419: UAE Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 420: UAE Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 421: UAE 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 422: UAE Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 423: UAE Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 424: UAE 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 425: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 426: Rest of Middle East Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 427: Rest of Middle East 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 428: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 429: Rest of Middle East Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 430: Rest of Middle East 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 431: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 432: Rest of Middle East Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 433: Rest of Middle East 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 434: Rest of Middle East Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 435: Rest of Middle East Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 436: Rest of Middle East 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AFRICA
    • Biotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 437: Africa Recent Past, Current & Future Analysis for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 438: Africa Historic Review for Biotechnology by Technology - DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 439: Africa 13-Year Perspective for Biotechnology by Technology - Percentage Breakdown of Value Sales for DNA Sequencing Technology, Nanobiotechnology Technology, Tissue Engineering & Regeneration Technology, PCR Technology, Chromatography Technology, Gene Amplification Technology, Synthetic Biology Technology, CRISPR & Gene-Editing Tools Technology, Biochips & Microarrays Technology and Other Technologies for the Years 2020, 2026 & 2032
    • TABLE 440: Africa Recent Past, Current & Future Analysis for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 441: Africa Historic Review for Biotechnology by Application - Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 442: Africa 13-Year Perspective for Biotechnology by Application - Percentage Breakdown of Value Sales for Health & Red Biotechnology Application, Food & Agriculture Application, Industrial Processing Application, Environmental & Natural Resources Application, Bioinformatics & Omics Application and Other Applications for the Years 2020, 2026 & 2032
    • TABLE 443: Africa Recent Past, Current & Future Analysis for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 444: Africa Historic Review for Biotechnology by Type - Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 445: Africa 13-Year Perspective for Biotechnology by Type - Percentage Breakdown of Value Sales for Biopharmaceuticals Type, Bioprocess Equipment & Consumables Type, Reagents & Kits Type, Bioservices Type, Bioinformatics Platforms & Software Type and Other Types for the Years 2020, 2026 & 2032
    • TABLE 446: Africa Recent Past, Current & Future Analysis for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 447: Africa Historic Review for Biotechnology by End-Use - Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 448: Africa 13-Year Perspective for Biotechnology by End-Use - Percentage Breakdown of Value Sales for Biopharma & Biotech Companies End-Use, CMOs & CROs End-Use, Academic & Research Institutes End-Use, Hospitals & Diagnostic Centers End-Use, Agricultural Corporations End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기